Sangamo Biosciences (SGMO) Worth Watching: Stock Surges 17.1%

Zacks

Sangamo Biosciences Inc. (SGMO) was a big mover last session, as the company saw its shares rise just over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the past one month’s volatile price range of $18.00 to $20.20.
 
This biopharmaceutical company has witnessed a mixed track record with estimate revisions of 2 increases and 1 decrease. The Zacks Consensus Estimate has also moved higher over the same time frame. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
 
Sangamo Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
 
Some better-ranked biomedical stocks worth considering are Alexion Pharmaceuticals, Inc. (ALXN), Gilead Sciences Inc. (GILD) and Biogen Idec Inc. (BIIB). While ALXN sports a Zacks Rank #1 (Strong Buy), GILD and BIIB bear a Zacks Rank #2 (Buy).
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



SANGAMO BIOSCIENCES INC (SGMO): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

(BIIB): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)